| QbD | Quality by Design |
| CQAs | Critical Quality Attributes |
| TPQP | Target Product Quality Profile |
| DoE | Design of Experiments |
| PAT | Process Analytical Technology |
| QC | Quality Control |
| HPLC | High-Performance Liquid Chromatography |
| CPPs | Process Parameters |
| ICH | International Council for Harmonisation |
| CMAs | Critical Material Attributes |
| FMEA | Failure Mode and Effects Analysis |
| QMS | Quality Management Systems |
| PROs | Patient-Reported Outcomes |
| RWE | Real-World Evidence |
| PFDD | Patient-Focused Drug Development |
| IVIVC | In Vitro-in Vivo Correlations |
| NIR | Near-Infrared Spectroscopy |
| ADCC | Alter antibody-Dependent Cellular Cytotoxicity |
| HCP | Host Cell Protein |
| SEC | Size Exclusion Chromatography |
| CE | Capillary Electrophoresis |
| PLS | Partial Least Squares |
| RSM | Response Surface Methodology |
| MVA | Multivariate Analysis |
| PCA | Principal Component Analysis |
| RTRT | Real-Time Release Testing |
| MPC | Model Predictive Control |
| CCPs | Critical Control Points |
| ANNs | Artificial Neural Networks |
| DNNs | Deep Neural Networks |
| RL | Reinforcement learning |
| PSD | Particle Size Distribution |
| CM | Continuous Manufacturing |
| OOS | Out-of-Specification |
| CHO | Chinese Hamster Ovary |
| MOI | Multiplicity of Infection |
| HA | Hemagglutinin |
| ATMPs | Advanced Therapy Medicinal Products |
| SLS | Selective Laser Sintering |
| FDM | Fused Deposition Modeling |
| BCS | Biopharmaceutics Classification System |